saascode
healthcare & clinical·run 293 · Jul 2026

Coredelta

A source-code migration analyzer that diffs versioned US Core implementation guides, maps changed profiles and search parameters to customer code, and generates reviewable remediation candidates plus regression-test scaffolds.

Genesis score7.38/10
Make Coredelta real.0/500
500 more votes and Coredelta is authorized for build.
0%500 to authorize
Backing is the vote. When an idea crosses 500, we pull it into the build pipeline and ship it for real — the votes decide what gets built next, not an editor.
The opportunity
8.0.1 + 9.0.0US Core versions cited
Nov 15, 2027Surveillance date cited
1 of 3Verified proposed APIs
The case

The 2026 SVAP includes US Core 8.0.1 and 9.0.0, while an open endpoint test framework and type generator validate adjacent tooling. No source-code impact analyzer was found. Coredelta fills the gap between specification diff and runtime conformance, but static analysis cannot prove every dynamic use, generated client, reflection path, stored resource, custom profile, or partner dependency. Findings must cite exact guide deltas and code evidence, preserve uncertainty, and feed—not replace—endpoint, integration, clinical, security, and certification testing.

Who pays — and why

The engineering, interoperability, product, quality, or certification team maintaining an ONC-certified health IT product or United States FHIR integration.

What it unlocks
A normalized guide-delta graph covering packages, profiles, elements, cardinality, bindings, invariants, extensions, search parameters, operations, examples, and terminology versions
Language- and framework-aware candidate references tied to exact files, symbols, queries, serializers, validators, tests, configuration, generated code, and evidence confidence
A reviewed migration plan with owner, severity, rationale, code change, generated test scaffold, endpoint test result, waiver, regression, and continuous watch
How Genesis scored it
7.38across seven criteria
tension 7temporal 9blindspot 5buyer 8leverage 8convergence 5why-not 8
9
Temporal window

August 2026 availability and 2027 surveillance create a planning window.

8
Buyer persona

FHIR engineering and certification teams have a concrete upgrade job.

5
Convergence

Several related migration ideas support the direction.

Why it scored well

A dated standards update, clear interoperability buyer, mature endpoint tests, and an unoccupied source-impact gap support the product.

What's holding it back

The source overstates universal mandatory migration, two interfaces are unverified, static analysis is incomplete, and no incumbent barrier exists.

Signals detected5 sources crossed
SignalONC research carried in Genesis

SignalONC research carried in Genesis

SignalONC research carried in Genesis

SignalInferno research carried in Genesis

Signalmarket scan carried in Genesis

Direction briefcoredelta.md
coredelta.md
Want this pointed at your vertical?Point Genesis at your own market and constraints — it invents adjacent, fork-ready ideas, private to you before they hit the public feed.

Discussion

?

No comments yet — be the first to weigh in.